Exploring the therapeutic mechanism of curcumin in prostate cancer using network pharmacology and molecular docking
Jun Li(Children’s Hospital of Fudan University Xiamen Branch), Qingmin He(Ankang City Central Hospital), Xue Li(Second Affiliated Hospital of Xi'an Jiaotong University), Xiong Wang(Ankang City Central Hospital)
Cited by 29
Related Papers
Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia
|Scientific Reports|2017|306
Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking
|Frontiers in Pharmacology|2023|127
Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments
|Frontiers in Pharmacology|2023|40
Knockdown of prostaglandin reductase 1 (PTGR1) suppresses prostate cancer cell proliferation by inducing cell cycle arrest and apoptosis
|BioScience Trends|2016|32
<p>Bruton’s Tyrosine Kinase (BTK) Inhibitor (Ibrutinib)-Suppressed Migration and Invasion of Prostate Cancer</p>
|OncoTargets and Therapy|2020|18